Success Metrics

Clinical Success Rate
83.3%

Based on 5 completed trials

Completion Rate
83%(5/6)
Active Trials
1(11%)
Results Posted
0%(0 trials)
Terminated
1(11%)

Phase Distribution

Ph phase_3
1
11%
Ph not_applicable
5
56%
Ph phase_2
2
22%

Phase Distribution

0

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
1(12.5%)
N/ANon-phased studies
5(62.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

1

trials recruiting

Total Trials

9

all time

Status Distribution
Active(1)
Completed(5)
Terminated(1)
Other(2)

Detailed Status

Completed5
unknown2
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
1
Success Rate
83.3%
Most Advanced
Phase 3

Trials by Phase

Phase 22 (25.0%)
Phase 31 (12.5%)
N/A5 (62.5%)

Trials by Status

completed556%
unknown222%
recruiting111%
terminated111%

Recent Activity

Clinical Trials (9)

Drug Details

Intervention Type
PROCEDURE
Total Trials
9